Pacemaker implantation due to cardiac conduction disease in patients with subsequent cardiac sarcoidosis may be a marker of early disease and is associated with adverse 5-year clinical outcome
Event: ESC Congress 2022
Topic: Atrioventricular (AV) Block
Session: Evaluation and treatment of conduction disease in 2022
